| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $129.5M | $120.9M | $102.0M |
| YoY Revenue Growth % | +7.1% | +18.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.41B | $1.32B | $1.17B |
| Operating Margin % | 1091.1% | 1095.0% | 1147.4% |
| Net Income (GAAP) | $974.0M | $854.7M | $803.2M |
| EBITDA (Normalized) | $1.42B | $1.33B | $1.17B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.85B | $1.89B | $1.40B |
| Capital Expenditures (CapEx) | $5.8M | $5.4M | $4.6M |
| Free Cash Flow (FCF) | $1.84B | $1.88B | $1.40B |
| FCF Margin % | 1424.5% | 1557.2% | 1370.7% |
| Return on Invested Capital (ROIC %) | 5.6% | 5.2% | 8.8% |
| Cash & Short-Term Equivalents | $138.9M | $138.2M | — |
| Total Debt (Short + Long Term) | $6.72B | $6.29B | $4.08B |
| Total Stockholders' Equity | $13.43B | $13.95B | $8.36B |